Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

July 9, 2013

Primary Completion Date

November 20, 2014

Study Completion Date

December 15, 2015

Conditions
PsoriasisPsoriatic ArthritisPsoriasis Arthropatica
Interventions
DRUG

Apremilast

20 mg tablet BID for 68 weeks

DRUG

Apremilast

20 mg tablet BID for 68 weeks

DRUG

Placebo

Placebo tablet BID for 16 weeks

Trial Locations (56)

812-0013

Ekihigashi Hifuka Clinic, Fukuoka

813-0042

Tsutsui Clinic Dermatology & Plastic Surgery, Fukuoka

814-0013

Yano Hifuka Hinyokika Clini, Fukuoka

814-0180

Fukuoka University Hospital, Fukuoka

815-0075

HATAMOTO Derma Clinic, Fukuoka

819-0167

Tomoko Matsuda Dermatological Clinic, Fukuoka

820-0040

TASHIRO Dermatological Clinic, Iizuka-shi

819-1108

Okubo Skin Care and Clinic, Itoshima-shi

819-1116

Matsuda Dermatology Clinic For Skin, Hair, Nail Diseases, Itoshima-shi

802-0077

Kitakyushu Municipal Medical Center, Kitakyushu

806-8501

Kyushu Kosei Nenkin Hospital, Kitakyushu

800-0296

Kyusyu Rosai Hospital, Kitakyushu-shi

830-0011

Kurume University Hospital, Kurume

819-0373

Matsuo Clinic, Nishiku

834-0034

Yame General Hospital, Yame

093-0016

Kokubu Medical Office Abashiri Dermatology Clinic, Abashiri-shi

066-0021

Chitose Dermatology Plastic Surgery Clinic, Chitose-shi

066-0064

Asanuma Dermatology Clinic, Chitose-shi

090-0832

Kokubu Dermatology, Kitami-shi

060-0063

Sapporo Skin Clinic, Sapporo

062-0042

Fukuzumi Dermatology Clinic, Sapporo

653-0013

Kobe City Medical Center, Kobe

317-0077

Hitachi General Hospital, Hitachi

300-0395

Tokyo Medical University Ibaraki Medical Center, Inashiki-gun

211-8510

Kanto Rosai Hospital, Kawasaki

213-8507

Teikyo University School of Medicine University Hospital, Kawasaki

Yokohama City University Hospital, Yokohama

212-0016

Kawasaki Saiwai Clinic, Kawasaki-shi

252-0392

Sagamihara National Hospital, Sagamihara

220-6208

Queen's Square Medical Facilities, Yokohama

221-0825

Nomura Dermatology Clinic, Yokohoma City

238-8558

Yokosuka Kyosai Hospital, Yokosuka

860-0016

Kosumi lin, Kumamoto

862-0975

Kumamoto Shinto General Hospital, Kumamoto

593-8324

Kume Derma Clinic, Sakai-Shi

330-0854

SANRUI Dermatology, Saitama-shi

329-0498

Jichi Medical University Hospital, Shimotsuke-shi

321-0954

Sugai Dermatologist Park Side Clinic, Utsunomiya

103-0016

Kayaba Dermatology Clinic, Cyu-o-ku

192-0032

Tokai University School of Medicine, Hachiōji

206-2801

Inagi Municipal Hospital, Inagi

174-0071

TSUTSUMI Clinic, Itabasi-Ku

136-0072

Koto Hospital, Koto-ku

136-0074

Maruyama Dermatology Clinic, Koto-ku

178-0063

OIZUMI HANAWA Clinic, Nerima-ku

158-0094

Kitahara Dermatology Clinic, Setagaya-ku

158-0097

NAOKO Dermatology Clinic, Setagaya-ku

108-0014

Mita Dermatology Clinic, Shiba Minato-k

141-8625

NTT Medical Center Tokyo, Shinagawa-ku

160-0023

Tokyo Medical University Hospital, Shinjyuku-ku

166-0015

Taneda Dermatology Clinic, Suginami-ku

190-8531

Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Tachikawa

750-0061

Shakaihoken Simonoseki Kosei Hospital, Shimonoseki-shi

719-0373

Matsuo Clinic, Fukuoka

530-0001

AMC Nishiumeda Clinic, Osaka

103-0028

Tokyo Center Clinic, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01988103 - Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis | Biotech Hunter | Biotech Hunter